Bangkok Genomics Innovation Public Company Limited (SET: BKGI) has reported to the Stock Exchange of Thailand the progress of the establishment of new subsidiaries and a joint venture that was approved during the Board of Directors Meeting No. 3/2024 held on August 14, 2024.
The details on the process of registering are as follows:
- The establishment of Omicsphere Company Limited with a registered capital of five million baht. The objective of this establishment is to distribute scientific devices, equipment, and chemicals used in laboratories.
- The establishment of Comprehensive Care Company Limited with a registered capital of five million baht. The objective of this establishment is to advance therapy medicinal products related to cells.
- The establishment of Biovision Tech Company Limited with a registered capital of four million baht. The objective of this establishment is to provide consulting services.
- The establishment of a joint venture Edge Medical (Thailand) Company Limited with a registered capital of four million baht, with BKGI holding 25% of the company’s shares. The objective of this establishment is the distribution of medical devices related to Surgical Robot.
